Abbas Jamali
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Abbas Jamali has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Asghar Abdoli
Department of Hepatitis and HIV, Pasteur Institute of Iran, Tehran, Iran
3 shared publications Masoumeh Tavassoti Kheiri
Influenza Research Lab, Department of Virology, Pasteur Institute of Iran, No. 358, 12th Farwardin Ave, Jomhhoori St, Tehran, Iran
2 shared publicationsMohammad Hasan Samiee Aref
Influenza Research Lab, Department of Virology, Pasteur Institute of Iran, No. 358, 12th Farwardin Ave, Jomhhoori St, Tehran, Iran
2 shared publicationsNarges Rasouli
Influenza Research Lab, Department of Virology, Pasteur Institute of Iran, No. 358, 12th Farwardin Ave, Jomhhoori St, Tehran, Iran
2 shared publications- Nasim Sadat Seyed Tabib
Department of Chronic Diseases, Metabolism and Ageing, TARGID, KU Leuven, Leuven, Belgium
2 shared publications Peyvand Biglari
Influenza Research Lab, Department of Virology, Pasteur Institute of Iran, No. 358, 12th Farwardin Ave, Jomhhoori St, Tehran, Iran
2 shared publications
Latest Publications
- 1 January 2019
- Published by Elsevier in Virus Research
- Vol. 259, 38-45
Molecular epidemiology of the hemagglutinin gene of prevalent influenza virus A/H1N1/pdm09 among patient in Iran
- 1 January 2019
- Published by Elsevier in Virus Research
- Vol. 259, 38-45
Molecular epidemiology of the hemagglutinin gene of prevalent influenza virus A/H1N1/pdm09 among patient in Iran
- Open Access
- 1 January 2017
- Published by American Institute of Mathematical Sciences (AIMS) in AIMS Microbiology
- Vol. 3 (4) , 899-907
Oil-in-water emulsion formulated with eucalyptus leaves extract inhibit influenza virus binding and replication in vitro
Throughout human history, the human-beings have been used different types of plants as antimicrobial agents in fight against infectious diseases. Influenza virus is one of the most common causes of respiratory infection and transmitted through direct contact with flu infected individuals and contaminated substances or droplets. In the current study, both oil-in-water and water-in-oil emulsions with hydroalcoholic extract of eucalyptus leaves (OLHE) were developed and their antiviral efficiency was evaluated. To doing so, Madin-Darbey Canine Kidney (MDCK) cells were treated with effective minimal cytotoxic concentration of the formulated emulsions. The treated cells were then infected with 50% cell culture infectious dose (100 CCID50) of the A/H1N1 virus (the swine flu). The viral titers were measured by hemagglutination (HA) and cell culture infectious dose 50% (CCID50) assays. Also, to check the virus binding inhibition via the formulated extract, the viruses were incubated with the formulated extracts. Our study showed that the oil-in-water emulsions formulated with 2% eucalyptus leaves extract inhibited virus replication completely when the cells were infected by 100 CCID50 and decreased HA titer up to four fold. Therefore, this formulation, may hold promising application to prevent influenza virus transmission through direct contact among children and passengers.
- 1 January 2017
- Published by American Institute of Mathematical Sciences (AIMS) in AIMS Microbiology
- Vol. 3 (4) , 899-907
Open AccessOil-in-water emulsion formulated with eucalyptus leaves extract inhibit influenza virus binding and replication in vitro
Throughout human history, the human-beings have been used different types of plants as antimicrobial agents in fight against infectious diseases. Influenza virus is one of the most common causes of respiratory infection and transmitted through direct contact with flu infected individuals and contaminated substances or droplets. In the current study, both oil-in-water and water-in-oil emulsions with hydroalcoholic extract of eucalyptus leaves (OLHE) were developed and their antiviral efficiency was evaluated. To doing so, Madin-Darbey Canine Kidney (MDCK) cells were treated with effective minimal cytotoxic concentration of the formulated emulsions. The treated cells were then infected with 50% cell culture infectious dose (100 CCID50) of the A/H1N1 virus (the swine flu). The viral titers were measured by hemagglutination (HA) and cell culture infectious dose 50% (CCID50) assays. Also, to check the virus binding inhibition via the formulated extract, the viruses were incubated with the formulated extracts. Our study showed that the oil-in-water emulsions formulated with 2% eucalyptus leaves extract inhibited virus replication completely when the cells were infected by 100 CCID50 and decreased HA titer up to four fold. Therefore, this formulation, may hold promising application to prevent influenza virus transmission through direct contact among children and passengers.
- 12 May 2016
- Published by Springer Nature in Biotechnology Letters
- Vol. 38 (8) , 1321-1329
A novel chimeric influenza virosome containing Vesicular stomatitis G protein as a more efficient gene delivery system
Objectives To enhance the efficiency of influenza virosome-mediated gene delivery by engineering this virosome. Results A novel chimeric influenza virosome was constructed containing the glycoprotein of Vesicular stomatitis virus (VSV-G), along with its own hemagglutinin protein. To optimize the transfection efficiency of both chimeric and influenza cationic virosomes, HEK cells were transfected with plasmid DNA and virosomes and the transfection efficiency was assessed by FACS analysis. The chimeric virosome was significantly more efficient in mediating transfection for all amounts of DNA and virosomes compared to the influenza virosome. Conclusions Chimeric influenza virosome, including VSV-G, is superior to the conventional influenza virosome for gene delivery.
- 12 May 2016
- Published by Springer Nature in Biotechnology Letters
- Vol. 38 (8) , 1321-1329
A novel chimeric influenza virosome containing Vesicular stomatitis G protein as a more efficient gene delivery system
Objectives To enhance the efficiency of influenza virosome-mediated gene delivery by engineering this virosome. Results A novel chimeric influenza virosome was constructed containing the glycoprotein of Vesicular stomatitis virus (VSV-G), along with its own hemagglutinin protein. To optimize the transfection efficiency of both chimeric and influenza cationic virosomes, HEK cells were transfected with plasmid DNA and virosomes and the transfection efficiency was assessed by FACS analysis. The chimeric virosome was significantly more efficient in mediating transfection for all amounts of DNA and virosomes compared to the influenza virosome. Conclusions Chimeric influenza virosome, including VSV-G, is superior to the conventional influenza virosome for gene delivery.
- 16 March 2016
- Published by Taylor & Francis in Journal of Liposome Research
- Vol. 27 (2) , 83-89
Introduction of cationic virosome derived from vesicular stomatitis virus as a novel gene delivery system for sf9 cells
Insect-derived cell lines are used extensively to produce recombinant proteins because they are capable of performing a range of post-translational modifications. Due to their significance in biotechnological applications, various methods have been developed to transfect them. In this study, we introduce a virosome constructed from vesicular stomatitis virus (VSV) as a new delivery system for sf9 cells. We labeled these VSV virosomes by fluorescent probe Rhodamine B chloride (R18). By fluorescence microscope observation and conducting a fusion assay, we confirmed the uptake of VSV virosomes via endocytosis by sf9 cells and their fusion with the endosomal membrane. Moreover, we incubated cationic VSV virosomes with a GFP-expressing bacmid and transfected sf9 cells, after 24 h some cells expressed GFP indicating the ability of VSV virosomes to deliver heterologous DNA to these cells. This is the first report of a virosome-based delivery system introduced for an insect cell line.
- 16 March 2016
- Published by Taylor & Francis in Journal of Liposome Research
- Vol. 27 (2) , 83-89
Introduction of cationic virosome derived from vesicular stomatitis virus as a novel gene delivery system for sf9 cells
Insect-derived cell lines are used extensively to produce recombinant proteins because they are capable of performing a range of post-translational modifications. Due to their significance in biotechnological applications, various methods have been developed to transfect them. In this study, we introduce a virosome constructed from vesicular stomatitis virus (VSV) as a new delivery system for sf9 cells. We labeled these VSV virosomes by fluorescent probe Rhodamine B chloride (R18). By fluorescence microscope observation and conducting a fusion assay, we confirmed the uptake of VSV virosomes via endocytosis by sf9 cells and their fusion with the endosomal membrane. Moreover, we incubated cationic VSV virosomes with a GFP-expressing bacmid and transfected sf9 cells, after 24 h some cells expressed GFP indicating the ability of VSV virosomes to deliver heterologous DNA to these cells. This is the first report of a virosome-based delivery system introduced for an insect cell line.
- 1 March 2012
- Published by S. Karger AG in Neuroimmunomodulation
- Vol. 19 (4) , 229-234
Withdrawal from Morphine Reduces Cell-Mediated Immunity against Herpes Simplex Virus Generated by Natural Immunization
In a previous study, the authors have shown that herpes simplex virus type 1 (HSV-1) glycoprotein B DNA vaccine but not live vaccine (non-virulent KOS strain) failed to induce protective immunity against acute HSV-1 challenge in morphine-dependent mice. The present study reports the effect of morphine withdrawal on protective immunity induced by live HSV-1 immunization. BALB/c mice were vaccinated with KOS strain as a live vaccine. Three weeks later, they were exposed to morphine for 14 days. On day 14, withdrawal was induced by administration of normal saline instead of morphine. One day later, immune responses against HSV-1 were assessed by measuring cytotoxicity, lymphocyte proliferation and interferon-γ production. Protection against HSV-1 was assessed by measuring the mortality rate after acute HSV-1 challenge. The results showed that withdrawal from morphine reduces protective immunity against acute HSV-1 challenge. These findings raise the possibility that withdrawal from morphine may increase the susceptibility of drug addicts to infectious diseases.
- 1 March 2012
- Published by S. Karger AG in Neuroimmunomodulation
- Vol. 19 (4) , 229-234
Withdrawal from Morphine Reduces Cell-Mediated Immunity against Herpes Simplex Virus Generated by Natural Immunization
In a previous study, the authors have shown that herpes simplex virus type 1 (HSV-1) glycoprotein B DNA vaccine but not live vaccine (non-virulent KOS strain) failed to induce protective immunity against acute HSV-1 challenge in morphine-dependent mice. The present study reports the effect of morphine withdrawal on protective immunity induced by live HSV-1 immunization. BALB/c mice were vaccinated with KOS strain as a live vaccine. Three weeks later, they were exposed to morphine for 14 days. On day 14, withdrawal was induced by administration of normal saline instead of morphine. One day later, immune responses against HSV-1 were assessed by measuring cytotoxicity, lymphocyte proliferation and interferon-γ production. Protection against HSV-1 was assessed by measuring the mortality rate after acute HSV-1 challenge. The results showed that withdrawal from morphine reduces protective immunity against acute HSV-1 challenge. These findings raise the possibility that withdrawal from morphine may increase the susceptibility of drug addicts to infectious diseases.